Anti-TNF agents target mucosal intercellular signaling in inflammatory bowel diseases: A common molecular mechanism of action of clinically effective Anti-TNF agents

被引：0
|
作者：
Atreya, Raja Narayana
Bartsch, Brigitte
Galle, Peter R.
Neurath, Markus F.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A644 / A644
页数：1
相关论文
共 50 条
  • [1] The Molecular Mechanism of Action of Clinically Effective Anti-TNF Antibodies in Inflammatory Bowel Diseases
    Atreya, Raja N.
    Zimmer, Michael
    Bartsch, Brigitte
    Galle, Peter R.
    Neurath, Markus F.
    GASTROENTEROLOGY, 2009, 136 (05) : A258 - A258
  • [2] Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseases
    Tilg, Herbert
    Moschen, Alexander
    Kaser, Arthur
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (07) : 1051 - 1059
  • [3] Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
    Levin, Alon D.
    Wildenberg, Manon E.
    van den Brink, Gijs R.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (08): : 989 - 997
  • [4] Hepatotoxicity of Anti-TNF Agents
    Maurizio Bonacini
    Marwan Ghabril
    Herbert L. Bonkovsky
    Digestive Diseases and Sciences, 2014, 59 : 1070 - 1071
  • [5] Hepatotoxicity of Anti-TNF Agents
    Bonacini, Maurizio
    Ghabril, Marwan
    Bonkovsky, Herbert L.
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (05) : 1070 - 1071
  • [6] Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents
    Marzo, M.
    Armuzzi, A.
    Felice, C.
    Forni, F.
    Papa, A.
    De Vitis, I
    Guidi, L.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S39 - S39
  • [7] Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease
    Peng, Jiang Chen
    Shen, Jun
    Ran, Zhi Hua
    JOURNAL OF DIGESTIVE DISEASES, 2014, 15 (11) : 585 - 590
  • [8] Common Adverse Effects of Anti-TNF Agents on Gestation
    Fasoulakis, Zacharias
    Antsaklis, Panagiotis
    Galanopoulos, Nikolaos
    Kontomanolis, Emmanuel
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2016, 2016
  • [9] Increased risk of psoriasiform diseases with anti-TNF agents
    Reactions Weekly, 2018, 1708 (1) : 9 - 9
  • [10] Efficacy of combination therapy with cyclosporin and vedolizumab in inflammatory bowel diseases refractory to anti-TNF agents
    Rutka, M.
    Szanto, K.
    Bor, R.
    Balint, A.
    Fabian, A.
    Molnar, T.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S375 - S375
12345